Arun Singh, M.D.
| Appointed: |
2003 |
| Gender: |
Male |
| Languages: |
English |
Ophthalmology
Translational Hematology and Oncology Research
Biographical Sketch
Arun D. Singh, MD, is Director of the Department of Ophthalmic Oncology in the Cole Eye Institute at Cleveland Clinic, Cleveland, Ohio. He is Fellow of the Royal College of Ophthalmologists, London, United Kingdom, and the American Board of Ophthalmology. He has published more than 160 scientific articles in peer-reviewed journals and has edited a major textbook, Clinical Ophthalmic Oncology, published by Elsevier. He is Editor of the British Journal of Ophthalmology.
Professional Highlights
- Editor, British Journal of Ophthalmology
- Editor, Clinical Ophthalmic Oncology
Education & Fellowships
| Medical School: | Jawaharlal Institute of Post Graduate Medical Education and Research, Pondicherry, India, India |
|
| Internship: | St. Luke's Hospital, Transitional, Bethlehem, PA |
| Residency: | University of Florida College of Medicine, Ophthalmology, Gainesville, FL |
| Fellowship: | Wills Eye Hospital, Ocular Oncology, Philadelphia, PA |
| Other Education: | (Other) Watford General Hospital, Watford, Hertfordshire, United Kingdom |
| Other Education: | (Undergraduate) University of Madras, Faculty of Medicine, Nadu, India |
Certifications
Ophthalmology
Royal College of Physicians of London - Ophthalmology
Specialty Interests
Eyelid and conjunctival tumors and von Hippel Lindau disease, retinoblastoma, Uveal Melanoma, Retinoblastoma.
Awards & Honors
Achievement Award, American Academy of Ophthalmology
Professional Memberships
- American Academy of Ophthalmology
- Royal College of Ophthalmologists, London, United Kingdom
- Royal College of Surgeons, Edinburgh, United Kingdom
- Association for Research in Vision and Ophthalmology
- International Society of Ocular Oncology
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Singh has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
